These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8480981)
61. [Treatment of cerebral ischemia with hyperbaric therapy]. Gismondi A; Micalella F; Metrangolo C; Colonna S Minerva Med; 1981 May; 72(22):1417-20. PubMed ID: 7243028 [No Abstract] [Full Text] [Related]
62. [Further data on therapeutic fibrinolysis]. Schmutzler R Helv Med Acta; 1963 Nov; 30(4):608-14. PubMed ID: 5878830 [No Abstract] [Full Text] [Related]
63. [Cerebellar forms of myocardial infarct]. Warembourg H; Niquet G; Lekieffre J; Ketelers JY Lille Med; 1967 Nov; 12(9):1199-202. PubMed ID: 5623877 [No Abstract] [Full Text] [Related]
64. Review of thrombolytic use in acute myocardial infarction, pulmonary embolism, and cerebral thrombosis. Burns D Crit Care Nurs Q; 1993 Feb; 15(4):1-12. PubMed ID: 8431790 [No Abstract] [Full Text] [Related]
65. [Fibrinogen substitution in systemic defibrination because of thrombolysis in acute myocardial infarction]. Ingerslev J; Nielsen TT; Eriksen UH Ugeskr Laeger; 1993 Mar; 155(12):893-4. PubMed ID: 8480390 [No Abstract] [Full Text] [Related]
66. Postinfarction ventricular thrombus and embolic risk: epidemiological data in the thrombolytic era. López-Sendón J; López de Sá E; Delcán JL G Ital Cardiol; 1994 Mar; 24(3):239-44. PubMed ID: 8063058 [No Abstract] [Full Text] [Related]
67. Addendum: a standardized nursing care plan for the acute myocardial infarction patient receiving tissue-type plasminogen activator. Erickson DE; Kleven M Heart Lung; 1987 Nov; 16(6 Pt 2):794-800. PubMed ID: 3119524 [No Abstract] [Full Text] [Related]
69. Thrombin generation and myocardial infarction during infusion of tissue-plasminogen activator. Baglin TP; Luddington R; Jennings I; Richards EM Lancet; 1993 Feb; 341(8843):504-5. PubMed ID: 8094535 [No Abstract] [Full Text] [Related]
70. Fibrinolysis in cardiac arrest. Baptista SB; Ferreira D; Ferreira R Rev Port Cardiol; 2004 Feb; 23(2):239-53. PubMed ID: 15116459 [TBL] [Abstract][Full Text] [Related]
71. [Frequency and clinical significance of congenital plasminogen abnormality in cerebral infarction]. Shinmyozu K; Maruyama Y; Osame M; Igata A; Ohkatsu Y Rinsho Shinkeigaku; 1986 Mar; 26(3):257-60. PubMed ID: 3731627 [No Abstract] [Full Text] [Related]
72. [Complications of blood donation. Myocerdial infarct and cerebral embolism following blood donation]. Schubbert E Z Arztl Fortbild (Jena); 1968 Jul; 62(13):713-5. PubMed ID: 5680507 [No Abstract] [Full Text] [Related]
73. Major arterial occlusion by embolisation of an occult thrombus following thrombolytic therapy for myocardial infarction. Kathula SK; Bhargava A Int J Clin Pract; 2001; 55(6):407-8. PubMed ID: 11501231 [TBL] [Abstract][Full Text] [Related]
74. THE EXPERIMENTAL STUDIES ON THE PATHOGENESIS OF HEMORRHAGIC INFARCTION AND ON THE APPLICATION OF FIBRINOLYTIC TREATMENTS FOR CEREBRAL INFARCTION IN DOGS. KONDO A Nihon Geka Hokan; 1965 Mar; 34():195-215. PubMed ID: 14310144 [No Abstract] [Full Text] [Related]
79. [Fibrinolytic therapy of cerebral embolism with streptokinase. Case report]. Bouschery R Med Welt; 1967 Oct; 43():2588-9. PubMed ID: 5610300 [No Abstract] [Full Text] [Related]